|
1
|
Hodson L, Skeaff CM and Fielding BA: Fatty
acid composition of adipose tissue and blood in humans and its use
as a biomarker of dietary intake. Prog Lipid Res. 47:348–380. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang C, Zhang J, Ding M, Xu K, Li L, Mao L
and Zheng J: Ki67 targeted strategies for cancer therapy. Clin
Transl Oncol. 20:570–575. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li J, Zhang Z, Chen F, Hu T, Peng W, Gu Q
and Sun Y: The diverse oncogenic and tumor suppressor roles of
microRNA-105 in cancer. Front Oncol. 9:5182019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dong P, Xiong Y, Yue J, Hanley SJB,
Kobayashi N, Todo Y and Watari H: Long Non-coding RNA NEAT1: A
novel target for diagnosis and therapy in human tumors. Front
Genet. 9:4712018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Panoutsopoulou K, Avgeris M and Scorilas
A: miRNA and long non-coding RNA: Molecular function and clinical
value in breast and ovarian cancers. Expert Rev Mol Diagn.
18:963–979. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song N, Kim K, Shin A, Park JW, Chang HJ,
Shi J, Cai Q, Kim DY, Zheng W and Oh JH: Colorectal cancer
susceptibility loci and influence on survival. Genes Chromosomes
Cancer. 57:630–637. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lech G, Słotwiński R, Słodkowski M and
Krasnodębski IW: Colorectal cancer tumour markers and biomarkers:
Recent therapeutic advances. World J Gastroenterol. 22:1745–1755.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Puccini A, Berger MD, Zhang W and Lenz HJ:
What we know about stage II and III colon cancer: It's still not
enough. Target Oncol. 12:265–275. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lan J, Sun L, Xu F, Liu L, Hu F, Song D,
Hou Z, Wu W, Luo X, Wang J, et al: M2 macrophage-derived exosomes
promote cell migration and invasion in colon cancer. Cancer Res.
79:146–158. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsukamoto S, Ishikawa T, Iida S, Ishiguro
M, Mogushi K, Mizushima H, Uetake H, Tanaka H and Sugihara K:
Clinical significance of osteoprotegerin expression in human
colorectal cancer. Clin Cancer Res. 17:2444–2450. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khamas A, Ishikawa T, Shimokawa K, Mogushi
K, Iida S, Ishiguro M, Mizushima H, Tanaka H, Uetake H and Sugihara
K: Screening for epigenetically masked genes in colorectal cancer
Using 5-Aza-2′-deoxycytidine, microarray and gene expression
profile. Cancer Genomics Proteomics. 9:67–75. 2012.PubMed/NCBI
|
|
14
|
R Core Team. R, . A language and
environment for statistical computing. R Foundation for Statistical
Computing. (Vienna, Austria). 2012.
|
|
15
|
RStudio Team. RStudio, . Integrated
development for R. RStudio, Inc. (Boston, MA). 2015.
|
|
16
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Krüger T: Editorial change at statistical
applications in genetics and molecular biology. Stat Appl Genet
Mol. 17(pii)2018.doi: 10.1515/sagmb-2018-0046.
|
|
18
|
Yu G, Wang L, Han Y and He Q:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43((Database Issue)): D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Henson DE, Hueman MT, Chen D, Patel JA,
Wang H and Schwartz AM: The anatomy of the TNM for colon cancer. J
Gastrointest Oncol. 8:12–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao X, Ponomaryov T, Ornell KJ, Zhou P,
Dabral SK, Pak E, Li W, Atwood SX, Whitson RJ, Chang AL, et al:
RAS/MAPK activation drives resistance to Smo inhibition,
metastasis, and tumor evolution in Shh pathway-dependent tumors.
Cancer Res. 75:3623–3635. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma D, Chen X, Zhang PY, Zhang H, Wei LJ,
Hu S, Tang JZ, Zhou MT, Xie C, Ou R, et al: Upregulation of the
ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor
growth. Oncogene. 37:1041–1048. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Duchartre Y, Kim Y and Kahn M: The Wnt
signaling pathway in cancer. Crit Rev Oncol Hematol. 99:141–149.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kalkat M, Resetca D, Lourenco C, Chan P,
Wei Y, Shiah Y, Vitkin N, Tong Y, Sunnerhagen M, Done SJ, et al:
MYC protein interactome profiling reveals functionally distinct
regions that cooperate to drive tumorigenesis. Mol Cell.
72:836–848.e7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stine ZE, Walton ZE, Altman BJ, Hsieh AL
and Dang CV: MYC, metabolism, and cancer. Cancer Discov.
5:1024–1039. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou J, Cheng M, Wu M, Boriboun C, Jujo K,
Xu S, Zhao TC, Tang Y, Kishore R and Qin G: Contrasting roles of
E2F2 and E2F3 in endothelial cell growth and ischemic angiogenesis.
J Mol Cell Cardiol. 60:68–71. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao Y, Feng B, Lu L, Han S, Chu X, Chen L
and Wang R: MiRNAs and E2F3: A complex network of reciprocal
regulations in human cancers. Oncotarget. 8:60624–60639.
2017.PubMed/NCBI
|
|
29
|
Lee SW, Li CF, Jin G, Cai Z, Han F, Chan
CH, Yang WL, Li BK, Rezaeian AH, Li HY, et al: Skp2-dependent
ubiquitination and activation of LKB1 is essential for cancer cell
survival under energy stress. Mol Cell. 57:1022–1033. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yao R, Han D, Sun X, Xie Y, Wu Q, Fu C,
Yao Y, Li H, Li Z and Xu K: Scriptaid inhibits cell survival, cell
cycle, and promotes apoptosis in multiple myeloma via epigenetic
regulation of p21. Exp Hematol. 60:63–72. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wall SJ, Zhong Z and DeClerck YA: The
Cyclin-dependent kinase inhibitors p15INK4B and p21CIP are critical
regulators of fibrillar collagen-induced tumor cell cycle arrest. J
Biol Chem. 282:24471–24476. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ansems M, Søndergaard JN, Sieuwerts AM,
Looman MW, Smid M, de Graaf AM, de Weerd V, Zuidscherwoude M,
Foekens JA, Martens JW and Adema GJ: DC-SCRIPT is a novel regulator
of the tumor suppressor gene CDKN2B and induces cell cycle arrest
in ERα-positive breast cancer cells. Breast Cancer Res Treat.
149:693–703. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang D, Han S, Peng R, Jiao C, Wang X,
Yang X, Yang R and Li X: Depletion of histone demethylase KDM5B
inhibits cell proliferation of hepatocellular carcinoma by
regulation of cell cycle checkpoint proteins p15 and p27. J Exp
Clin Cancer Res. 35:372016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park J, Park M, Oh EH, Soung N, Lee SJ,
Jung J, Lee O, Yun SJ, Kim W, Shin E and Kim EG: The p21-activated
kinase 4-Slug transcription factor axis promotes
epithelial-mesenchymal transition and worsens prognosis in prostate
cancer. Oncogene. 37:5147–5159. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dutto I, Tillhon M, Cazzalini O, Stivala
LA and Prosperi E: Biology of the cell cycle inhibitor p21CDKN1A:
Molecular mechanisms and relevance in chemical toxicology. Arch
Toxicol. 89:155–178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Basudan A, Priedigkeit N, Hartmaier RJ,
Sokol ES, Bahreini A, Watters RJ, Boisen MM, Bhargava R, Weiss KR,
Karsten MM, et al: Frequent ESR1 and CDK pathway copy number
alterations in metastatic breast cancer. Mol Cancer Res.
17:457–468. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Z, Qiu R, Qiu X and Tian T: SNHG6
promotes tumor growth via repression of P21 in colorectal cancer.
Cell Physiol Biochem. 49:463–478. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang Z, Li J, Huang Y, Peng W, Qian W, Gu
J, Wang Q, Hu T, Ji D, Ji B, et al: Upregulated miR-1258 regulates
cell cycle and inhibits cell proliferation by directly targeting
E2F8 in CRC. Cell Prolif. 51:e125052018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen Z, Hou R, Gao S, Song D and Feng Y:
Baicalein inhibits proliferation activity of human colorectal
cancer cells HCT116 through downregulation of Ezrin. Cell Physiol
Biochem. 49:2035–2046. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Del CS, Sayagues JM, Bengoechea O, Anduaga
MF, Alcazar JA, Gervas R, Garcia J, Orfao A, Bellvis LM, Sarasquete
ME and Del Mar Abad M: Spatio-temporal tumor heterogeneity in
metastatic CRC tumors: A mutational-based approach. Oncotarget.
9:34279–34288. 2018.PubMed/NCBI
|
|
41
|
Xie XN, Yu J, Zhang LH, Luo ZY, Ouyang DS,
Zheng LJ, Wang CY, Yang L, Chen L and Tan ZR: Relationship between
polymorphisms of the lipid metabolism-related gene PLA2G16 and risk
of colorectal cancer in the Chinese population. Funct Integr
Genomic. 19:227–236. 2019. View Article : Google Scholar
|
|
42
|
Yu C, Hong H, Lu J, Zhao X, Hu W, Zhang S,
Zong Y, Mao Z, Li J, Wang M, et al: Prediction of target genes and
pathways associated with cetuximab insensitivity in colorectal
cancer. Technol Cancer Res Treat. 17:2018.doi:
10.1177/1533033818806905. View Article : Google Scholar
|
|
43
|
Xue W, Li J, Wang F, Han P, Liu Y and Cui
B: A long non-coding RNA expression signature to predict survival
of patients with colon adenocarcinoma. Oncotarget. 8:101298–101308.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lin Y, Wang X, Yu Y, Liu W, Xie F, Ouyang
X and Huang Q: Expression and prognostic significance of
cyclin-dependent kinase inhibitor 1A in patients with resected
gastric adenocarcinoma. Oncol Lett. 14:7473–7482. 2017.PubMed/NCBI
|
